Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 21, 2015; 21(11): 3223-3231
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3223
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3223
Noninvasive test | Parameters | Disease | AUC | Ref. |
APRI | AST, platelet count | Fibrosis, cirrhosis in mixed patient population | 0.82 | Adler et al[40], Hepatology (2008) |
Enhanced liver fibrosis (ELF) test | Hyaluronic acid, tissue inhibitor of matrix metalloproteinase-1, amino terminal propeptide of procollagen type III | NAFLD in children | 0.92 to 0.99 | Nobili et al[50], Gastroenterology (2009) |
Chronic liver disease | 0.80 | Nobili et al[50], Gastroenterology (2009) | ||
HAIR | Hypertension, ALT, IR index | NAFLD | 0.90 | Dixon et al[31], Gastroenterology (2001) |
NashTest | Alpha2-macroglobulin, haptoglobin, apolipoprotein A1, total bilirubin, GGT, fasting glucose, triglycerides, cholesterol, ALT, AST, age, gender, weight, height | NAFLD | 0.79 | Poynard et al[34], BMC Gastroenterology (2006) |
A commercial panel from Biopredictive, France | ||||
FIB-4 | Platelets, ALT, AST and age | HCV fibrosis | 0.76 | Vallet-Pichard et al[38], Hepatology 2006 |
NAFLD fibrosis | 0.80 | Shah et al[39], Clinical Gastroenterology and Hepatology (2009) | ||
FibroTest/FibroSure | α2-macroglobulin , apolipoprotein A1, haptoglobin, total bilirubin, GGT | NAFLD fibrosis | 0.86 | Ratziu et al[37], BMC gastroenterology (2006) |
A commercial panel from Biopredictive, France | ||||
Age, AST, platelet | HCV fibrosis | 0.783 | Hsieh et al[41], Chang Gung Med J (2009) | |
FibroQ | Count, PT-INR | (F2-4) | ||
Lok index | Platelet count, PT-INR, AST, ALT | HCV fibrosis | 0.78 | Lok et al[42], Hepatology (2005) |
Forns Score | Age, platelet count, | HCV fibrosis | 0.86 | Forns X et al, Hepatology (2002) |
GGT, cholesterol | Fibrosis from all causes | 0.76 | Adler et al[40], Hepatology (2008) | |
BARD Score | Body-mass index, AST/ALT ratio, type 2 diabetes mellitus | NAFLD fibrosis | 0.67 | Ruffillo et al[47], Journal of Hepatology (2011) |
NAFLD fibrosis score | Age, hyperglycemia, body mass index, platelet count, albumin, and AST/ALT ratio | NAFLD fibrosis | 0.82 | Angulo et al[45], Hepatology (2007) |
0.68 | Ruffillo et al[47], Journal of Hepatology (2011) | |||
Fibrometer | Platelets, prothrombin index, aspartate aminotransferase, α2-macroglobulin (A2M), hyaluronate, urea, and age | Viral and alcoholic chronic liver diseases fibrosis | 0.883 | Calès et al[43], Hepatology (2005) |
NAFLD | 0.943 | Calès et al[44], Journal of Hepatology (2009) |
- Citation: Sanal MG. Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes? World J Gastroenterol 2015; 21(11): 3223-3231
- URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3223.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i11.3223